BioSpace News Archive

Dental Implants Market Emerging Analysis, Future Growth and Business Opportunities 2027

The dental implants market was valued at US$ 3,872.3 million in 2018 and it is projected to reach US$ 7,417.4 million in 2027; it is expected to grow at a CAGR of 7.6% from 2019 to 2027.

July 1, 2021
·
4 min read
Genetown

Exacis Biotherapeutics Makes Strategic Investment In Manufacturing by Hiring Head of Technical Operations and Securing Space in a GMP Cleanroom Facility Recently Completed by Factor Bioscience

Exacis today announced two significant advances in its manufacturing capabilities.

July 1, 2021
·
3 min read
High Intensity Focused Ultrasound Therapy Market 2020 by Technology, Trends, Share, Revenue, Top Companies, Segmentation to 2027

The High-Intensity Focused Ultrasound Therapy market was valued at US$ 417.98 million in 2018 and it is projected to reach US$ 755.46 million by 2027; it is expected to grow at a CAGR of 7.1% from 2019 to 2027.

July 1, 2021
·
4 min read
Deals

MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals

MorphoSys AG today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended for its tender offer for Constellation Pharmaceuticals, Inc.

July 1, 2021
·
7 min read
Structural Heart Market Set to Witness Thriving Growth Worldwide during 2020-2025

The report highlights the trends prevalent in the global structural heart market and the factors driving the market along with the restraints that are impacting its growth.

July 1, 2021
·
4 min read
Business

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its financial results for the second quarter of 2021 on Wednesday, July 28, 2021 at 7:00 a.m. ET.

July 1, 2021
·
2 min read
Business

Medivir appoints Malene Jensen as VP Clinical Development

Medivir AB (Nasdaq Stockholm: MVIR) announced today it has appointed Malene Jensen as Vice President Clinical Development

July 1, 2021
·
2 min read
BioCapital

RegeneRx Biopharmaceuticals, Inc. Closes $2 Million Private Placement

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration), announced that it closed its previously announced private placement offering of common stock and warrants for gross proceeds of $1,980,000.

July 1, 2021
·
3 min read
Genetown

Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock

Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the pricing of its previously announced underwritten public offering of 14,000,000 shares of common stock at a public offering price of $25.00 per share

July 1, 2021
·
6 min read
Diabetic Retinopathy Market Size to Reach USD 15.01 Billion in 2028

Rising prevalence of diabetes and increasing incidences of blindness among people with severe diabetic conditions are expected to fuel the global market growth.

July 1, 2021
·
5 min read